Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204437
Max Phase: Preclinical
Molecular Formula: C40H39ClN6O7
Molecular Weight: 751.24
Associated Items:
ID: ALA5204437
Max Phase: Preclinical
Molecular Formula: C40H39ClN6O7
Molecular Weight: 751.24
Associated Items:
Canonical SMILES: CC1(C)[C@H](NC(=O)c2ccc3c(c2)C(=O)N(CCCNc2cccc4c2C(=O)N(C2CCC(=O)NC2=O)C4=O)C3)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1
Standard InChI: InChI=1S/C40H39ClN6O7/c1-39(2)37(40(3,4)38(39)54-24-12-11-22(19-42)27(41)18-24)45-32(49)21-9-10-23-20-46(34(51)26(23)17-21)16-6-15-43-28-8-5-7-25-31(28)36(53)47(35(25)52)29-13-14-30(48)44-33(29)50/h5,7-12,17-18,29,37-38,43H,6,13-16,20H2,1-4H3,(H,45,49)(H,44,48,50)/t29?,37-,38-
Standard InChI Key: LZLNZRASVFBVRQ-YDGCRVERSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 751.24 | Molecular Weight (Monoisotopic): 750.2569 | AlogP: 4.68 | #Rotatable Bonds: 10 |
Polar Surface Area: 178.01 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.59 | CX Basic pKa: 2.30 | CX LogP: 4.24 | CX LogD: 4.24 |
Aromatic Rings: 3 | Heavy Atoms: 54 | QED Weighted: 0.20 | Np Likeness Score: -0.58 |
1. Guo L, Zhou Y, Nie X, Zhang Z, Zhang Z, Li C, Wang T, Tang W.. (2022) A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions., 236 [PMID:35397401] [10.1016/j.ejmech.2022.114317] |
Source(1):